• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ALLERGAN (PRINGY) VOLBELLA WITH LIDOCAINE; IMPLANT, DERMAL, FOR AESTHETIC USE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ALLERGAN (PRINGY) VOLBELLA WITH LIDOCAINE; IMPLANT, DERMAL, FOR AESTHETIC USE Back to Search Results
Catalog Number 96183
Medical Device Problem Code Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Code Nodule (4551)
Date of Event 08/06/2023
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
Clarification to section c.Suspect product: lot number 963/3.Continued h.6.Type of investigation code: b15, b17, b20.Clarification to h.6.Type of investigation code: the filler was injected into the patient and is not accessible for return.The syringe was not returned for evaluation.The event is a physiological complication and analysis of the device generally does not assist abbvie in determining a probable cause for this event.A review of the device history record has been initiated.If any new, changed or corrected information is noted, a supplemental medwatch will be submitted.This is a known potential adverse event addressed in the product labeling.
 
Event or Problem Description
Hcp reported injecting a patient in the lips with one syringe of juvéderm volbella® xc.18 days later, patient was injected in the lips with an additional syringe of juvéderm volbella® xc.54 days later, patient started experiencing swelling in the lips, bruising in the lips, warm lips, and bumps on lips.The swelling in the lips, the lips were warm, and bumps were all related as they are inflammatory nodules.Eight days later, patient was provided benadryl, kenalog shot, and antibiotics as treatment.Event resolved about a month and a half later.This is the same event and the same patient reported under mdr id# 3005113652-2023-00931 (abbvie complaint #(b)(4)).This mdr is being submitted for the second suspect product, juvéderm volbella® xc.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VOLBELLA WITH LIDOCAINE
Common Device Name
IMPLANT, DERMAL, FOR AESTHETIC USE
Manufacturer (Section D)
ALLERGAN (PRINGY)
route de promery
zone artisanale de pre-mairy
pringy
Manufacturer (Section G)
ALLERGAN (PRINGY)
route de promery
zone artisanale de pre-mairy
pringy
Manufacturer Contact
terry ingram
12331-a riata trace parkway
building 3
austin, TX 78727
8479366324
MDR Report Key18336434
Report Number3005113652-2023-00932
Device Sequence Number20936347
Product Code LMH
UDI-Device Identifier10888628043565
UDI-Public10888628043565
Combination Product (Y/N)Y
Initial Reporter StateCA
Initial Reporter CountryUS
PMA/510(K) Number
P110033
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2023
Reporter Type Manufacturer
Report Source Health Professional
Initial Reporter Occupation Nurse Practitioner
Type of Report Initial
Report Date (Section B) 12/15/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Expiration Date08/02/2024
Device Catalogue Number96183
Device Lot Number1000541101
Was Device Available for Evaluation? No
Type of Report(Section G)Initial
Initial Date Received by Manufacturer 12/13/2023
Initial Report FDA Received Date12/15/2023
Was Device Evaluated by Manufacturer? (Y/N) Device Not Returned to Manufacturer
Date Device Manufactured09/02/2022
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient Age31 YR
Patient SexFemale
-
-